Patents Assigned to Complegen Partners, LLC
  • Compounds and methods for PKC? inhibition
    Patent number: 8664277
    Abstract: The present invention provides a method of selectively inhibiting PKC? in the presence of PKC?, by administering to a subject in need thereof, a therapeutically effective amount of a compound of Formula I. The present invention also provides a method of inhibiting cytokine synthesis in a T cell, a method of inhibiting T cell proliferation, and a method of inhibiting the replication of and cytokine production by T lymphocytes, while not stimulating or inhibiting the replication of B lymphocytes.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: March 4, 2014
    Assignee: CompleGen Partners, LLC
    Inventors: Janet Ajioka, Heidi S. Hummel, Rich B. Meyer, John Swindle
  • COMPOUNDS AND METHODS FOR PKC THETA INHIBITION
    Publication number: 20130225687
    Abstract: The present invention provides a method of selectively inhibiting PKC? in the presence of PKC?, by administering to a subject in need thereof, a therapeutically effective amount of a compound of Formula I. The present invention also provides a method of inhibiting cytokine synthesis in a T cell, a method of inhibiting T cell proliferation, and a method of inhibiting the replication of and cytokine production by T lymphocytes, while not stimulating or inhibiting the replication of B lymphocytes.
    Type: Application
    Filed: April 12, 2013
    Publication date: August 29, 2013
    Applicant: Complegen Partners, LLC
    Inventor: Complegen Partners, LLC